Effect of drug formulation on the treatment of epilepsy
The paper describes a trial dealing with the effect of the formulation of an antiepileptic drug on therapy efficiency, safety, and compliance in epileptic patients. Switching from sustained-release valproates to Depakine®Chronosphere™ demonstrates how the values of efficiency, safety, and compliance...
Main Author: | S. G. Burd |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2013-12-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/214 |
Similar Items
-
Is there a universal drug for epilepsy?
by: S. G. Burd, et al.
Published: (2018-08-01) -
EXPERIENCE OF PROLONGED VALPROATE USE IN ADULT PATIENTS WITH FOCAL FORMS OF EPILEPSY (RESULTS OF OBSERVATION HELD IN OUT-PATIENT CLINICS OF MOSCOW)
by: S. G. Burd, et al.
Published: (2016-09-01) -
NEW OPPORTUNITIES IN TREATMENT OF EPILEPSY IN CHILDREN, ADOLESCENTS, ADULTS AND ELDERLY – DEPAKINE® CHRONOSPHERE™ (RUSSIAN CLINICAL PRACTICE)
by: G. N. Avakyan, et al.
Published: (2016-05-01) -
Partial epilepsies: Choice of antiepileptic drugs in adults in the outpatient setting
by: P. N. Vlasov
Published: (2016-07-01) -
Use of depakine chronosphere as a first monotherapy to treat epilepsy in children
by: E. D. Belousova, et al.
Published: (2010-09-01)